Steve Schonfeld’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $4.07M | Sell |
7,723
-7,280
| -49% | -$4.08M | 0.01% | 731 |
|
|
2026
Q1 | $8.43M | Buy |
+15,003
| New | +$9.62M | 0.06% | 341 |
|
|
2025
Q4 | – | Sell |
-8,291
| Closed | -$5.3M | – | 2276 |
|
|
2025
Q3 | $5.3M | Buy |
8,291
+7,542
| +1,007% | +$4.58M | 0.03% | 563 |
|
|
2025
Q2 | $402K | Buy |
+749
| New | +$358K | ﹤0.01% | 1610 |
|
|
2025
Q1 | – | Sell |
-9,280
| Closed | -$3.84M | – | 2332 |
|
|
2024
Q4 | $3.84M | Buy |
9,280
+5,085
| +121% | +$2.23M | 0.02% | 593 |
|
|
2024
Q3 | $2.12M | Buy |
+4,195
| New | +$2.04M | 0.01% | 853 |
|
|
2023
Q4 | – | Sell |
-8,201
| Closed | -$3.59M | – | 2029 |
|
|
2023
Q3 | $3.59M | Sell |
8,201
-317
| -4% | -$158K | 0.03% | 644 |
|
|
2023
Q2 | $4.28M | Buy |
8,518
+5,652
| +197% | +$2.71M | 0.04% | 532 |
|
|
2023
Q1 | $1.43M | Buy |
+2,866
| New | +$1.37M | 0.01% | 797 |
|
|
2022
Q4 | – | Sell |
-4,932
| Closed | -$1.61M | – | 2790 |
|
|
2022
Q3 | $1.61M | Sell |
4,932
-4,814
| -49% | -$1.77M | 0.01% | 977 |
|
|
2022
Q2 | $3.42M | Buy |
9,746
+8,317
| +582% | +$3.39M | 0.03% | 577 |
|
|
2022
Q1 | $782K | Buy |
+1,429
| New | +$752K | 0.01% | 1121 |
|
|
2021
Q2 | – | Sell |
-8,480
| Closed | -$4.15M | – | 2105 |
|
|
2021
Q1 | $4.15M | Buy |
8,480
+5,680
| +203% | +$2.85M | 0.05% | 478 |
|
|
2020
Q4 | $1.4M | Buy |
+2,800
| New | +$1.25M | 0.02% | 699 |
|
|
2020
Q1 | – | Sell |
-5,468
| Closed | -$1.43M | – | 1314 |
|
|
2019
Q4 | $1.43M | Buy |
+5,468
| New | +$1.44M | 0.03% | 409 |
|
|
2019
Q3 | – | Sell |
-2,300
| Closed | -$633K | – | 1121 |
|
|
2019
Q2 | $633K | Buy |
2,300
+1,000
| +77% | +$246K | 0.02% | 570 |
|
|
2019
Q1 | $291K | Buy |
+1,300
| New | +$268K | 0.01% | 841 |
|
|
2018
Q4 | – | Sell |
-32,200
| Closed | -$8.04M | – | 1143 |
|
|
2018
Q3 | $8.04M | Sell |
32,200
-15,811
| -33% | -$3.84M | 0.36% | 65 |
|
|
2018
Q2 | $10.5M | Buy |
48,011
+26,439
| +123% | +$5.45M | 0.57% | 21 |
|
|
2018
Q1 | $4.13M | Sell |
21,572
-3,469
| -14% | -$640K | 0.31% | 94 |
|
|
2017
Q4 | $3.92M | Sell |
25,041
-10,721
| -30% | -$1.69M | 0.32% | 89 |
|
|
2017
Q3 | $5.56M | Buy |
35,762
+33,664
| +1,605% | +$5.32M | 0.51% | 54 |
|
|
2017
Q2 | $339K | Buy |
+2,098
| New | +$341K | 0.03% | 451 |
|
Other funds holding IDXX
Steve Schonfeld's IDXX Position: Q2 2026 in Review
Steve Schonfeld reduced its Idexx Laboratories (IDXX) stake by 49% in Q2 2026, selling an estimated $4.08M and leaving 7,723 shares worth $4.07M. The position accounts for 0.01% of the portfolio, ranked #731.
Steve Schonfeld first reported a position in IDXX in Q2 2017 and has held it in 23 quarters since. The position peaked at $10.5M in Q2 2018. 1,293 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.
- Steve Schonfeld held 7,723 shares of Idexx Laboratories worth $4.07M as of Q2 2026.
- Steve Schonfeld sold 7,280 Idexx Laboratories shares in Q2 2026, an estimated $4.08M.
- Idexx Laboratories made up 0.01% of Steve Schonfeld's portfolio in Q2 2026, its #731 holding.
- Steve Schonfeld first reported a position in Idexx Laboratories in Q2 2017 and has held it in 23 quarters since.
- Steve Schonfeld's Idexx Laboratories position peaked at $10.5M in Q2 2018.
- 1,293 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.
Based on Schonfeld Strategic Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.